NASDAQ:LPCN - Lipocine Price Target & Analyst Ratings

$1.85
+0.03 (+1.65 %)
(As of 07/23/2019 04:00 PM ET)
Today's Range
$1.81
Now: $1.85
$1.91
50-Day Range
$1.44
MA: $1.78
$1.97
52-Week Range
$1.04
Now: $1.85
$2.64
Volume207,400 shs
Average Volume428,546 shs
Market Capitalization$45.46 million
P/E RatioN/A
Dividend YieldN/A
Beta0.98

Analyst Ratings

Lipocine (NASDAQ:LPCN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Lipocine in the last 12 months. Their average twelve-month price target is $3.25, suggesting that the stock has a possible upside of 75.68%. The high price target for LPCN is $5.00 and the low price target for LPCN is $1.50. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.672.75
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.25$3.25$2.25$4.8333
Price Target Upside: 75.68% upside68.39% upside9.22% upside140.46% upside

Lipocine (NASDAQ:LPCN) Consensus Price Target History

Lipocine (NASDAQ:LPCN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/15/2019HC WainwrightReiterated RatingBuy$5.00LowView Rating Details
1/17/2019LADENBURG THALM/SH SHReiterated RatingBuyHighView Rating Details
8/10/2018Canaccord GenuityReiterated RatingHold$1.50HighView Rating Details
3/29/2018Seaport Global SecuritiesInitiated CoverageBuy$10.00MediumView Rating Details
8/10/2017Roth CapitalSet Price TargetBuy$38.00MediumView Rating Details
(Data available from 7/23/2017 forward)
This page was last updated on 7/23/2019 by MarketBeat.com Staff

Featured Article: Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel